Asymmetric Synthesis of MK-7845, an Investigational Treatment for COVID-19
- Journal:
- Organic Letters
- Published:
- DOI:
- 10.1021/acs.orglett.5c03920
- Affiliations:
- 3
- Authors:
- 41
| Institutions | Authors | Share |
|---|---|---|
| Merck - Rahway, United States of America (USA) | 0.95 | |
| Changzhou SynTheAll Pharmaceutical, China | 0.05 |